In addition, it has been shown that hypomorphic missense variants in the DNA binding domain of BRCA2 with partial effects on protein function may confer moderate risks of breast cancer28, being the hypomorphic variants associated with this domain the only missense variants in BRCA2 increasing cancer risk. Here, BRCA2 is linked to cancer.